Cardiovascular consequences of cortisol excess
- PMID: 17315601
- PMCID: PMC1993964
- DOI: 10.2147/vhrm.2005.1.4.291
Cardiovascular consequences of cortisol excess
Abstract
Cushing's syndrome is a consequence of primary or, more commonly, secondary oversecretion of cortisol. Cardiovascular disease is the major cause of morbidity and mortality in Cushing's syndrome, and excess risk remains even in effectively treated patients. The cardiovascular consequences of cortisol excess are protean and include, inter alia, elevation of blood pressure, truncal obesity, hyperinsulinemia, hyperglycemia, insulin resistance, and dyslipidemia. This review analyses the relationship of cortisol excess, both locally and at tissue level, to these cardiovascular risk factors, and to putative mechanisms for hypertension. Previous studies have examined correlations between cortisol, blood pressure, and other parameters in the general population and in Cushing's syndrome. This review also details changes induced by short-term cortisol administration in normotensive healthy men.
Comment in
-
Corticosteroids and endothelial dysfunction.Vasc Health Risk Manag. 2005;1(4):261-2. doi: 10.2147/vhrm.2005.1.4.261. Vasc Health Risk Manag. 2005. PMID: 17315598 Free PMC article. No abstract available.
Similar articles
-
Pathogenetic aspects of hypertension in Cushing's syndrome.Cardiology. 1985;72 Suppl 1:84-90. doi: 10.1159/000173950. Cardiology. 1985. PMID: 3902234
-
Ambulatory blood pressure monitoring-derived short-term blood pressure variability is increased in Cushing's syndrome.Endocrine. 2014 Nov;47(2):557-63. doi: 10.1007/s12020-014-0164-7. Epub 2014 Jan 10. Endocrine. 2014. PMID: 24408053
-
Hypertension in Cushing's syndrome.Best Pract Res Clin Endocrinol Metab. 2006 Sep;20(3):467-82. doi: 10.1016/j.beem.2006.07.006. Best Pract Res Clin Endocrinol Metab. 2006. PMID: 16980206 Review.
-
[Cardiovascular diseases and lipid abnormalities in Cushing's syndrome].Nouv Presse Med. 1982 Sep 18;11(36):2693-8. Nouv Presse Med. 1982. PMID: 7145656 French.
-
Cushing, cortisol, and cardiovascular disease.Hypertension. 2000 Nov;36(5):912-6. doi: 10.1161/01.hyp.36.5.912. Hypertension. 2000. PMID: 11082166 Review.
Cited by
-
Associations between circulating cardiovascular disease risk factors and cognitive performance in cognitively healthy older adults from the NuAge study.Front Aging Neurosci. 2023 Nov 10;15:1274794. doi: 10.3389/fnagi.2023.1274794. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38020779 Free PMC article.
-
Psychological Distress and Hypertension: Results from the National Health Interview Survey for 2004-2013.Cardiorenal Med. 2016 May;6(3):198-208. doi: 10.1159/000443933. Epub 2016 Feb 25. Cardiorenal Med. 2016. PMID: 27275156 Free PMC article.
-
Allostatic Stress and Inflammatory Biomarkers in Transgender and Gender Expansive Youth: Protocol for a Pilot Cohort Study.JMIR Res Protoc. 2021 May 19;10(5):e24100. doi: 10.2196/24100. JMIR Res Protoc. 2021. PMID: 34009131 Free PMC article.
-
Circulating endothelial cell enumeration demonstrates prolonged endothelial damage in recipients of myeloablative allogeneic stem cell transplantation.Haematologica. 2015 Jun;100(6):e246-9. doi: 10.3324/haematol.2014.121731. Epub 2015 Feb 20. Haematologica. 2015. PMID: 25710454 Free PMC article. No abstract available.
-
Changes in Precarious Employment and Health in the United States Amidst the COVID-19 Pandemic.Prev Med Rep. 2023 Feb;31:102113. doi: 10.1016/j.pmedr.2023.102113. Epub 2023 Jan 16. Prev Med Rep. 2023. PMID: 36688136 Free PMC article.
References
-
- Agrest A, Finkielman S, Elijovich F. Hemodynamics of arterial hypertension in Cushing's syndrome. Medicina (B Aires) 1974;34:457–62. - PubMed
-
- Andrews RC, Herlihy O, Livingstone DE, et al. Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance. J Clin Endocrinol Metab. 2002;87:5587–93. - PubMed
-
- Andrews RC, Walker BR. Glucocorticoids and insulin resistance: old hormones, new targets. Clin Sci. 1999;96:513–23. - PubMed
-
- Berger J, Tanen M, Elbrecht A, et al. Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11beta-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem. 2001;276:12629–35. - PubMed
-
- Bjorntorp P, Rosmond R. Obesity and cortisol. Nutrition. 2000;16:924–36. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical